BRITISH JOURNAL OF OPHTHALMOLOGY, cilt.103, sa.4, ss.463-468, 2019 (SCI-Expanded)
Background To evaluate the functional long-term outcome in patients with macular oedema (MO) secondary to central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO) treated with dexamethasone implant (DEX implant) and to identify its clinical predictors.